Normal Kidney Cortex Thickness on Ultrasound and CT
The renal cortex is the outer parenchymal layer of the kidney, housing the glomeruli and proximal tubules responsible for filtration and reabsorption. Accurate measurement of cortical thickness is a fundamental step in evaluating overall renal parenchymal health. Thinning or loss of cortical tissue directly correlates with nephron loss and reduced functional reserve, making it a critical imaging biomarker in chronic kidney disease and obstructive uropathy.
Normal Reference Values
| Measurement |
|---|
| 2.6-10.6 mm |
Clinical Significance
A cortical thickness of 2.6–10.6 mm represents the normal range across a large asymptomatic adult population. Cortical thinning below this range suggests parenchymal loss, which may be diffuse (as in chronic kidney disease or global ischemia) or focal (post-infarct scarring, reflux nephropathy). Conversely, apparent cortical thickening or heterogeneity may indicate infiltrative or inflammatory processes.
Serial measurements are more informative than a single value; progressive thinning over time is a stronger indicator of deteriorating renal function than any absolute threshold. Pitfalls include pseudo-thinning from severe hydronephrosis compressing the parenchyma, and overestimation in patients with prominent columns of Bertin, which are normal cortical extensions into the medulla.
- Chronic kidney disease (CKD): Diffuse bilateral cortical thinning with increased echogenicity
- Obstructive uropathy: Progressive parenchymal loss from sustained elevated pelvic pressure
- Renal artery stenosis / ischemic nephropathy: Unilateral cortical thinning with a small kidney
- Reflux nephropathy: Focal polar scarring with overlying cortical depression
- Renal infarct: Wedge-shaped cortical thinning in the subacute or chronic phase
Reference: Glodny, B. et al. Normal kidney size and its influencing factors – a 64-slice MDCT study of 1.040 asymptomatic patients. BMC Urology 2009, 9:19.
Imaging Notes
Ultrasound: Cortical thickness is best measured on a longitudinal or transverse view at the mid-pole, from the outer capsular margin to the base of the medullary pyramid. Use a high-frequency linear or curvilinear probe in a cooperative, breath-held patient. Avoid measuring over columns of Bertin or renal sinus fat, as these can distort the cortex-medulla boundary.
CT (MDCT): On contrast-enhanced CT, the nephrographic phase (90–120 seconds post-injection) provides optimal corticomedullary differentiation for thickness assessment. Measure perpendicularly from the capsule to the corticomedullary junction on axial or reformatted images. Unenhanced CT reduces measurement reliability due to poor soft-tissue contrast between cortex and medulla.